Sir Chris Whitty tells the Covid-19 Inquiry the NHS has 'slipped backwards' since the pandemic at sharing vital patient data, ...
A HUGE study that has been launched to find treatments for diseases by measuring how the proteins circulating in our bodies ...
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
MHRA’s independence also questioned during Commons debate, with regulator accused of being too close to companies it ...
Dr. Patrick Hemmons travelled to Seattle, Wash., to get an RSV shot for his daughter. He says he hopes to see ...
British drug maker AstraZeneca Plc (AZN.L, AZN) and Daiichi Sankyo (DSKYF.PK) announced Monday that their Datroway (datopotamab ...
Funding for climate tech has contracted in recent years. What makes Gothenburg so unique in its ability to fund, scale and ...
Daiichi Sankyo shares rose sharply after the U.S. Food and Drug Administration approved its breast cancer drug Datroway. Shares were recently 8.7% higher at 4,437 yen, equivalent to $28.39, on Monday ...
AstraZeneca faces significant challenges amid Chinese investigation and ongoing investor lawsuit regarding alleged misconduct ...
Trapped-ion quantum computing leader IonQ (NYSE: IONQ) is emerging as a potential leader in the commercialization of quantum ...
A drug from AstraZeneca and Daiichi Sankyo won authorization for a form of breast cancer, the first U.S. approval for the ...
The U.S. Food and Drug Administration approved AstraZeneca (AZN, AZN.L) and Daiichi Sankyo's (DSKYF.PK) Datroway (datopotamab ...